SBI HEALTHCARE OPPORTUNITIES FUND - Direct Plan - IDCW

SBI Mutual Fund · Sectoral/Thematic · Direct · IDCW

NAV · as of 11/09/2026

420.97

-0.28%

+21.41%

Key stats

Expense ratio: 1.02%
AUM: ₹5.80 K Cr
Launched: 01/01/2013
Fund manager: Tanmaya Desai
Portfolio turnover: 0.35%
Risk: Very High Risk
Min lump-sum: ₹5,000
Min SIP: ₹500/mo
Fresh lump-sum: Accepted
Fresh SIP: Accepted

NAV history

SBI HEALTHCARE OPPORTUNITIES FUND - Direct Plan - IDCW

13/08/2026 to 11/09/2026

O - H - L -

1W+0.76%

1M+0.49%

3M+11.05%

6M+25.96%

1Y+21.41%

3Y+24.49%

5Y+18.66%

MAX+745.99%

Top holdings

36 disclosed

1.
Sun Pharmaceuticals Industries Ltd
Healthcare
11.18%
2.
Acutaas Chemicals Ltd
Basic Materials
6.35%
3.
Divi's Laboratories Ltd
Healthcare
5.92%
4.
Apollo Hospitals Enterprise Ltd
Healthcare
5.21%
5.
Max Healthcare Institute Ltd Ordinary Shares
Healthcare
5.08%
6.
Aurobindo Pharma Ltd
Healthcare
4.17%
7.
Aster DM Healthcare Ltd Ordinary Shares
Healthcare
3.77%
8.
Laurus Labs Ltd
Healthcare
3.64%
9.
Cipla Ltd
Healthcare
3.52%
10.
Torrent Pharmaceuticals Ltd
Healthcare
3.33%
11.
Biocon Ltd
Healthcare
3.14%
12.
Treps
3.03%
13.
Gland Pharma Ltd
Healthcare
3.00%
14.
Fortis Healthcare Ltd
Healthcare
2.87%
15.
Mankind Pharma Ltd
Healthcare
2.85%
16.
Anthem Biosciences Ltd
Healthcare
2.84%
17.
Aether Industries Ltd
Basic Materials
2.72%
18.
Jupiter Life Line Hospitals Ltd
Healthcare
2.56%
19.
Sai Life Sciences Ltd
Healthcare
2.47%
20.
Sudeep Pharma Ltd
Healthcare
2.31%
21.
Krishna Institute of Medical Sciences Ltd
Healthcare
2.17%
22.
Poly Medicure Ltd
Healthcare
2.16%
23.
Ajanta Pharma Ltd
Healthcare
2.05%
24.
Lonza Group Ltd ADR
Healthcare
2.04%
25.
Cohance Lifesciences Ltd
Healthcare
2.01%
26.
Lupin Ltd
Healthcare
1.94%
27.
Concord Biotech Ltd
Healthcare
1.84%
28.
Global Health Ltd
Healthcare
1.47%
29.
Abbott India Ltd
Healthcare
1.22%
30.
Nephrocare Health Services Ltd
Healthcare
1.08%
31.
Dr. Lal PathLabs Ltd
Healthcare
0.99%
32.
Rainbow Childrens Medicare Ltd
Healthcare
0.85%
33.
Gufic Biosciences Ltd
Healthcare
0.41%
34.
Net Receivable / Payable
0.26%
35.
Day Tbill
0.06%
36.
Alkem Laboratories Ltd
-

Sector allocation

Healthcare88.10%
Basic Materials9.07%
Unclassified3.36%

Comparable peers

SBI Healthcare Opportunities IDCW Reinvest Direct Plan
SBI Healthcare Opportunities IDCW Reinvest (DR) · ₹5.80 K Cr AUM
1Y+22.13%
3Y+24.61%
-
SBI Healthcare Opportunities IDCW Payout Direct Plan
SBI Healthcare Opportunities IDCW Payout (DP) · ₹5.80 K Cr AUM
1Y+22.13%
3Y+24.61%
-
HDFC Transportation & Logistics IDCW Reinvest Direct Plan
HDFC Transportation & Logistics IDCW Reinvest (DR) · ₹1.96 K Cr AUM
1Y+9.79%
3Y+25.46%
-
HDFC Transportation & Logistics IDCW Reinvest Direct Plan
HDFC Transportation & Logistics IDCW Reinvest (DR) · ₹1.96 K Cr AUM
1Y+9.79%
3Y+25.46%
-
HDFC Transportation & Logistics IDCW Payout Direct Plan
HDFC Transportation & Logistics IDCW Payout (DP) · ₹1.96 K Cr AUM
1Y+9.79%
3Y+25.46%
-

Investment objective

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

Scheme details

Scheme code: 119782
Fund house: SBI Mutual Fund
Category: Open Ended
Type: Equity Scheme
Sub-category: Sectoral/Thematic
Plan: Direct
Return type: IDCW
ISIN (Growth): INF200K01UN7
ISIN (Div. Reinvest): INF200K01UO5
Tradable on exchange: No

Kuvera page